Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 4 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting.
Cancer Med. 2023 Sep;12(17):17914-17923. doi: 10.1002/cam4.6430. Epub 2023 Aug 11.
Cancer Med. 2023.
PMID: 37568276
Free PMC article.
Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Kondapalli L, Worth S, Hawi R, Vachhani P, Arora G, Bhatia R, Lenneman CG.
Kondapalli L, et al. Among authors: worth s.
Vasc Med. 2020 Jun;25(3):246-254. doi: 10.1177/1358863X20906868. Epub 2020 Apr 17.
Vasc Med. 2020.
PMID: 32303152
Review.
Item in Clipboard
Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia.
Jamy O, Lin K, Worth S, Bachiashvili K, Rangaraju S, Vachhani P, Bhatia R.
Jamy O, et al. Among authors: worth s.
Br J Haematol. 2022 Aug;198(3):e35-e37. doi: 10.1111/bjh.18229. Epub 2022 May 4.
Br J Haematol. 2022.
PMID: 35509246
No abstract available.
Item in Clipboard
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
Zainaldin C, Arora S, Bathini S, Gupta U, Pandya V, Bae S, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P.
Zainaldin C, et al. Among authors: worth s.
Leuk Lymphoma. 2022 Dec;63(13):3245-3248. doi: 10.1080/10428194.2022.2113530. Epub 2022 Sep 15.
Leuk Lymphoma. 2022.
PMID: 36107006
No abstract available.
Item in Clipboard
IDH1 inhibitor-induced neutrophilic dermatosis in a patient with acute myeloid leukemia.
Dunn-Valadez S, Bathini S, Elston C, Rangaraju S, Stasi AD, Worth S, Morlote D, Harada S, Vachhani P.
Dunn-Valadez S, et al. Among authors: worth s.
Cancer Treat Res Commun. 2022;31:100560. doi: 10.1016/j.ctarc.2022.100560. Epub 2022 Apr 14.
Cancer Treat Res Commun. 2022.
PMID: 35460975
Free article.
Item in Clipboard
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen.
Dunn-Valadez S, Bathini S, Purdy KE, Bachiashvili K, Bhatia R, Jamy O, Rangaraju S, Mehta A, Godby K, Goyal G, Worth S, Oliver JD, Mikhail FM, Choi JK, Morlote D, Reddy VB, Vachhani P.
Dunn-Valadez S, et al. Among authors: worth s.
Leuk Lymphoma. 2023 Oct;64(10):1673-1680. doi: 10.1080/10428194.2023.2234529. Epub 2023 Jul 26.
Leuk Lymphoma. 2023.
PMID: 37493540
Item in Clipboard
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia.
Arora S, Zainaldin C, Bathini S, Gupta U, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P.
Arora S, et al. Among authors: worth s.
Leuk Res. 2022 Jun;117:106844. doi: 10.1016/j.leukres.2022.106844. Epub 2022 Apr 25.
Leuk Res. 2022.
PMID: 35487134
Item in Clipboard
Cite
Cite